|
Factors
| |
Negative (%)
|
Positive (%)
|
χ2
|
P value
|
|---|
|
Sex
|
male
|
394 (82)
|
88 (18)
|
3.01
|
0.08
|
|
female
|
154 (76)
|
49 (24)
|
|
Site
|
lower
|
359 (80)
|
91 (20)
|
0.95
|
0.81
|
|
middle
|
74 (83)
|
15 (17)
|
|
upper
|
92 (78)
|
22 (26)
|
|
entire
|
23 (82)
|
5 (18)
|
|
Age (year)
|
mean (SD)
|
58.4 (10.3)
|
56.7 (12.2)
|
2.88*
|
0.09
|
|
Size (cm)
|
mean (SD)
|
5.4 (2.4)
|
5.7 (2.5)
|
1.64*
|
0.20
|
|
Infiltrating pattern
|
INF α/β
|
317 (88)
|
42 (12)
|
32.49
|
<0.01
|
|
INF γ
|
231 (71)
|
95 (29)
| | |
|
Differentiation
|
well/moderate
|
175 (86)
|
29 (14)
|
6.08
|
0.01
|
|
poor
|
373 (78)
|
108 (22)
|
|
Borrmann type
|
I/II
|
97 (90)
|
11 (10)
|
7.72
|
<0.01
|
|
III/IV
|
451 (78)
|
126 (22)
|
|
Lauren type
|
intestinal
|
172 (85)
|
30 (15)
|
4.88
|
0.09
|
|
mixed
|
17 (81)
|
4 (19)
|
|
diffuse
|
359 (78)
|
103 (22)
| | |
|
Depth of invasion
|
dMP
|
106 (86)
|
17 (14)
|
3.58
|
0.06
|
|
SS
|
442 (79)
|
120 (21)
| | |
|
Lymphatic/venous invasion
|
-
|
444 (80)
|
109 (20)
|
0.15
|
0.69
|
|
+
|
104 (79)
|
28 (21)
|
|
TNM stage
|
N0(0)
|
170 (86)
|
27 (14)
|
23.21
|
<0.01
|
|
N1 (1–2)
|
114 (81)
|
27 (19)
|
|
N2 (3–6)
|
128 (85)
|
23 (15)
|
|
N3a (7–15)
|
101 (72)
|
39 (28)
|
|
N3b (>15)
|
35 (63)
|
21 (37)
|
|
JCGC stage
|
N0
|
170 (86)
|
27 (14)
|
15.57
|
<0.01
|
|
N1
|
173 (83)
|
36 (17)
|
|
N2
|
184 (75)
|
62 (25)
|
|
>N3
|
21 (64)
|
12 (36)
|
|
FCCs #
|
negative
|
84 (85)
|
15 (15)
|
27.46
|
<0.01
|
| |
positive
|
4 (25)
|
12 (75)
| | |
- * Unpaired t-test; # analysis only included 115 patients with intraoperative cytological examination.
